ロード中...
The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia
Friedreich’s ataxia (FA) is a trinucleotide repeats expansion neurodegenerative disorder, for which no cure or approved therapies are present. In most cases, GAA trinucleotide repetitions in the first intron of the FXN gene are the genetic trigger of FA, determining a strong reduction of frataxin, a...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7037688/ https://ncbi.nlm.nih.gov/pubmed/32019240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21030916 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|